Corient Capital Partners, LLC Moderna, Inc. Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,500 shares of MRNA stock, worth $181,445. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,500
Previous 5,382
2.19%
Holding current value
$181,445
Previous $769,000
2.21%
% of portfolio
0.06%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
917Shares Held
255MCall Options Held
19.2MPut Options Held
24.7M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.33 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.28 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$843 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$580 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$241 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...